1LUBLIN F D, REINGOLD S C. Defining the clinical course of multiple sclerosis: results of an international survey[J]. Neurology, 1996, 46(4): 907-911.
2TRAP B D, PETERSON J, RANSOHOFF R M, et al. Axonal transaction in the lessions of multiple sclerosis[J]. N Engl J Med, 1998, 338(5): 278-285.
3MILLER A E, MORGANTE L A, BUCHWALD L Y, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis[J]. Neurology, 1997, 48(2): 312-314.
4BIANCA W G, LANWENCE D J. What is new in the treatment of multiple sclerosis[J]. Drugs, 2000, 59(3): 401-410.
5RUNKEL L, MEIER W, PEPINSKY B, et al. Structural analysis of human interferon beta(IFN β): studies addrenssing the activity differences between IFN β-1a and IFN β-1b[J]. Mult Scler, 1997, 3: 337.
6JOHN H N, CLAUDIA L, MOSES R. Multiple sclerosis[J]. N Engl J Med, 2000, 343(13): 938-952.
7JOHNSON K P, BROOKS B R, COHEN J A, et al. Extended use of Glatiramer acetate(Copaxone) is well to tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability[J]. Neurology, 1998, 50(3): 701-708.
8POEHLAU D. Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins interim results on drug safety of an ongoing study. IVIG study group[J]. Mult Scler, 2000, (Supple): 21-23.
9HARTUNG H P, GONSETTE R. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled randomized, observe-blind phase Ⅲ trial: clinical results and three-year follow-up[J]. Neurology, 1999, 52: 290.
10ROMINE J S, SIPE J C, KOZIOL J A, et al. A double-blind placebo-contralled randomized trial of cladribine in relapsing-remitting multiple sclerosis[J]. Proc Assoc Am Physicians, 1999, 111(1): 35-44.
二级参考文献10
1Nash RA,MeSweeney PA,Storb R,et al.Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis paradigm for autoimmune disease[].The Journal of Rheumatology.1997
2Francis GS,Evans AC,Aronold DL.Neuroimaging in multiple sclerosis[].Neurologic Clinics.1995
3Burt RK,Burns WH,Miller SD.Bone marrow transplantation for multiple sclerosis : returning to pandora′s box[].Immunology Today.1997
4Burt RK,Padilla J,Begolka WS,et al.Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing EAE[].Blood.1998
5Ikehara S.Bone marrow transplantation for autoimmune diseases[].Acta Haematologica.1998
6Karussis,Vourka-karussis U,Lehmann D,et al.Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation[].The Journal of Clinical Investigation.1993
7Van Gelder M,Van Bekkum DW.Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation[].Bone Marrow Transplantation.1996
8Van Gelder M,Van Bekkum DW.Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain[].Bone Marrow Transplantation.1995
9Burt RK,Traynor AE,Cohen B,et al.T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients[].Bone Marrow Transplantation.1998
10Tyndall A,Gratwohl A.Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League against Rheumatism(EULAR) and the european group for blood and marrow transplantation(EBMT)[].Bone Marrow Transplantation.1997
